Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Johnson et al, 2011, USA | 4 Volunteer participants (2 men, 2 women) 23–35 years of age, screened to be previously psychologically and physically healthy. Effect of ascending weight-based doses of Salvinorin A, administered by inhalation, over the course of 20 sessions | Double-blind and placebo controlled trial | Time course of acute drug effects | Mean peak effect at 2 minutes post-inhalation, Mean end of effect at 20 minutes. | Very small sample size. Sampled only health adults who had previously used other hallucinogens. Uncertainty of generalizability of doses of drug given in this study to common doses of commercially available drug. |
Effect on blood pressure and heart rate | No statistically significant effect at any dose | ||||
Psychobehavioral effects observed | No psychomotor agitation observed, patients were generally behaviorally inactive. Brief epsiodes of verbal unresponsiveness at high doses. High subjective scores of \\\'positive\\\' and \\\'drug liking\\\' responses | ||||
Addy, 2012, USA | 30 pre-screened adult volunteers from ages 25-65 who self reported physical and psychological health and self reported hallucinogen use. | Case series | Physiological measures before and after drug | Mild decreases in diastolic blood pressure (4 mm Hg) and pulse (5 bpm). No other statistically significant alterations. | Small sample size. Volunteers healthy and had used hallucinogens before. Vitals signs not taken during period of intoxication. Absolute dosing (rather than weight based) used. Uncertain dosing generalizability. Participants were allowed to self-administer the drug, likely leading to idiosyncratic dose delivery. |
Behavioral effects during session | Statistically significant behaviors included: increased movement while sitting, laughing, increased physical contact, paranoia, and increase talking. | ||||
Self reported psychological effects | The drug increased ratings on all six clusters in the Hallucinogen Rating Scale: affect, cognition, intensity, perception, somaesthesia, and volition. | ||||
Self reported after-effects at 8 week followup | Few negative effects lasting greater than 24h noted: headache, fatigue, difficulty concentrating, and mood lability. At 8 weeks, 87% stated they would like to use the drug again. | ||||
Vohra et al, 2011, USA | 133 cases of exposure to Salvia spp. 37 of these cases were exposures to the hallucinogenic Salivia divinorum. All of these were intentional and recreational exposures. These patients range in age from 15 years to 44 years. 37 of these cases were exposures to the hallucinogenic S. divinorum | Retrospective case review | Deaths | None | Retrospective study with a small sample size. Many entries were missing objective clinical information, such as vital signs. Many patients left against medical advice, and were lost to follow up. |
Case referred to a health facility | 33/37 cases | ||||
Concomitant intoxication with other drugs | 19/37 cases | ||||
Clinical symptoms in isolated S. divinorum exposure | Symptoms noted include nausea, anxiety, confusion, hallucinations, laughter, tachycardia |